Carbomer

1. INCI & CAS

INCI: Carbomer · CAS: pending supplier / regulatory confirmation for the selected grade

2. Role in the formula

Carbomer is carried as a named cosmetic ingredient for this SKU. Identity, assay and impurities are confirmed on the supplier TDS and COA. This page does not invent a CAS or a drug effect.

3. Typical use levels (formulation guide)

• Set the use level from the supplier TDS for the finished formula.

Use the supplier TDS for solvent, temperature and pH.

4. Regulatory sources & global compliance

• CosIng information about Carbomer does not itself authorize a particular grade or finished cosmetic.
• The EU Cosmetics Regulation (EC) No 1223/2009 requires a safety review of the finished cosmetic in which Carbomer is used for the specific product as it will be marketed.
• Verify the purchased Carbomer grade using supplier data, alongside the applicable filing rules for the destination market.

5. Safety & risk assessment

This formulation note gives a cosmetic-use reference level; it should not be read as a drug authorization or OTC listing so the finished cosmetic should receive patch and stability checks.

6. Stability & packaging

Keep bulk material sealed, cool, and out of direct sunlight; take oxidation sensitivity into account when selecting the final pack; check the final package and formula together for compatibility and stability.

7. Claims language (Do / Don’t)

• Names Carbomer as a cosmetic ingredient on this SKU

• This reference provides no basis for drug effects, clinical cures, or unsupported product certifications.
• The documented facts for Carbomer does not establish skin whitening, treatment of acne, sweat control, UV protection, or hair-growth results.

1. INCI & CAS

INCI: Glycerin · CAS: 56-81-5

2. Role in the formula

For emulsions, gels, and washes, this guide assigns glycerin a polyol-humectant role. Its level is not a batch assay.

3. Typical use levels (formulation guide)

• The level shown for gels and serums is 3–8% as a formulation guide.
• The guide range for creams is 2–5%.
• Rinse-off: 2–4% in this reference.

The water phase is the addition point for Glycerin; a separate melt is unnecessary.

4. Regulatory sources & global compliance

• A CosIng entry naming Glycerin does not by itself approve the purchased grade or complete cosmetic.
• The EU Cosmetics Regulation (EC) No 1223/2009 requires an assessment of the safety of the final cosmetic containing Glycerin before release of the finished cosmetic.
• Match the selected Glycerin material to its supplier TDS and check the filing list for the market of sale.

5. Safety & risk assessment

Treat the listed amount as cosmetic-development guidance; it makes no claim of drug or OTC authorization with patch response and finished-product stability still to be verified.

6. Stability & packaging

Store the bulk in a closed container in a cool, shaded place; match the pack choice to the system's oxidation risk; assess the confirmed formula for stability and package compatibility.

7. Claims language (Do / Don’t)

• The formulation note describes Glycerin as part of a cosmetic direction focused on humectant function.

• The development record does not substantiate drug or therapeutic claims, clinical cures, or certification claims not confirmed for the product.
• This guide to Glycerin cannot verify whitening, acne treatment, antiperspirant action, sunscreen use, or hair-growth outcomes.

1. INCI & CAS

INCI: Squalane · CAS: 111-01-3

2. Role in the formula

As a hydrocarbon emollient, squalane offers stability; the grade in this guide is plant-derived rather than mineral oil.

3. Typical use levels (formulation guide)

• Gel-creams may use the guide range 2–6% as a formulation guide.
• The level shown for dry oils is 10–30% in this reference.
• For balms, the recorded level is 5–15% in this reference.

The oil phase is the addition point for Squalane, with no high-shear wax operation.

4. Regulatory sources & global compliance

• Database information on Squalane does not replace review of the supplied grade and finished product under market rules.
• Before EU placement, Regulation (EC) No 1223/2009 requires the complete cosmetic containing Squalane to receive its own safety assessment before the cosmetic is placed on the EU market.
• Establish grade-specific details for Squalane from the supplier and assess filing requirements in the intended market.

5. Safety & risk assessment

The concentration shown is guidance for cosmetic formulation; no drug approval or OTC status is conferred by this entry and the finished formula still needs patch and stability testing.

6. Stability & packaging

Use cool, sealed storage away from strong light for the bulk; evaluate packaging against the formula's susceptibility to oxidation; verify the chosen pack against the tested formula.

7. Claims language (Do / Don’t)

• The cosmetic formulation concept for Squalane centers on a light-emollient role.

• The ingredient record is not evidence of claims of drug activity, a clinical cure, or an undocumented product certification.
• The cosmetic guidance for Squalane does not support whitening, acne care as treatment, perspiration reduction, sun protection, or hair growth.